您的购物车当前为空
别名 SB 271046A
SB 271046 hydrochloride (SB 271046A) 是高效、选择性和具有口服活性的5-HT6受体拮抗剂,对大鼠、猪和人的pKi 分别为 9.02、8.55 和 8.81。它增加额叶皮层中的细胞外天冬氨酸和谷氨酸并表现出抗惊厥活性,EC50为 0.16 μM。它对 5-HT6 受体、结合位点和离子通道的选择性超过 200 倍。


为众多的药物研发团队赋能,
让新药发现更简单!
SB 271046 hydrochloride (SB 271046A) 是高效、选择性和具有口服活性的5-HT6受体拮抗剂,对大鼠、猪和人的pKi 分别为 9.02、8.55 和 8.81。它增加额叶皮层中的细胞外天冬氨酸和谷氨酸并表现出抗惊厥活性,EC50为 0.16 μM。它对 5-HT6 受体、结合位点和离子通道的选择性超过 200 倍。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 137 | In stock | |
| 2 mg | ¥ 191 | In stock | |
| 5 mg | ¥ 283 | In stock | |
| 10 mg | ¥ 479 | In stock | |
| 25 mg | ¥ 1,060 | In stock | |
| 50 mg | ¥ 1,990 | In stock | |
| 100 mg | ¥ 2,890 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 368 | In stock |
SB 271046 hydrochloride 相关产品
| 产品描述 | SB 271046 hydrochloride (SB 271046A) is selective, orally active 5-HT6 antagonist (pKi values are 9.02-8.92, 6.35, 6.55, 6.27 at 5-HT6, 5-HT1A, 5-HT1D and D3, and 6.05, 5.95, 5.76, 5.73, 5.62, 5.55, 5.41, 5.39, 5.27 and < 4.99 at 5-HT1B, 5-HT1F, α1B, 5-HT2C, 5-HT2A, D2, 5-HT2B, 5-HT7, 5-HT4 and 5-HT1E respectively) and is > 200-fold selective over 55 other receptors, enzymes and ion channels. It increases extracellular aspartate and glutamate in the frontal cortex and exhibits anticonvulsant activity (EC50: 0.16 μM). |
| 靶点活性 | 5-HT1B receptor:6.05 (pKi), 5-HT4 receptor:5.27 (pKi), 5-HT1A receptor:6.35 (pKi), 5-HT2C receptor (human):5.73 (pKi), 5-HT1E:<4.99 (pKi), 5-HT1F receptor:5.95 (pKi), 5-HT7 receptor:5.39 (pKi), 5-HT2A receptor:5.62 (pKi), 5-HT2B receptor:5.41 (pKi), 5-HT6:8.92(pKi), 5-HT1D receptor:6.55 (pKi) |
| 别名 | SB 271046A |
| 分子量 | 488.45 |
| 分子式 | C20H22ClN3O3S2·HCl |
| CAS No. | 209481-24-3 |
| Smiles | Cl.C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (92.13 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.09 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容